The study, conducted by researchers with the Centers for Disease Control and Prevention (CDC), found that six bacterial ...

The agent MRX-I, an oral oxazolidinone antibiotic, targets infections due to multi-drug resistant Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and ...

Exposure to the antibiotics did not increase the risk for vancomycin-resistant Enterococcus colonization. Few patients tested positive for VRE overall, so the authors said more research is needed.

Dalba vancin and oritavancin have shown bactericidal activity against MRSA, VRSA, VRE, and DRSP and are undergoing the final stages of clinical trials (Bradley, 2005; Hoffman-Roberts et al., ...

Increased VISA growth in diabetic infection Vancomycin is frequently used to treat MRSA-associated bacteremia. Infection with vancomycin intermediate-resistance S. aureus (VISA) strains are three ...

While the prevalence of VISA and VRSA remains low, concerns about vancomycin resistance and the lack of a clinical or bacteriological response with as many as 18% of MRSA isolates with a ...

Department of Chemistry, University of California, Irvine, Irvine, California 92697, United States Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California 92697, ...

Weifang Key Laboratory of Respiratory Tract Pathogens and Drug Therapy, School of Life Science and Technology, Shandong Second Medical University, Weifang 261000, P. R. China ...

No association was observed between age and MRSA infection risk. Of 1,392,470 VRE surveillance tests, 2.8% were positive, representing 16,707 unique patients (median age, 75 [IQR, 64-85] years; women, ...